Correct Answer: A. CPR with 20% intralipid
This clinical presentation describes local anesthetic systemic toxicity (LAST) from bupivacaine, manifesting as cardiovascular collapse (unresponsiveness, absent pulse). Bupivacaine, a long-acting amide local anesthetic, is highly lipophilic and cardiotoxic. When absorbed systemically in toxic doses, it causes profound myocardial depression, arrhythmias, and cardiovascular collapse refractory to standard ACLS drugs.
20% lipid emulsion (Intralipid) is the definitive antidote for LAST. The mechanism involves lipid sequestration: the lipid phase acts as a "lipid sink," extracting bupivacaine from the myocardium and central nervous system, reducing free drug concentration and restoring cardiac contractility. The ASRA (American Society of Regional Anesthesia) guidelines, now adopted in Indian anesthesia practice, recommend immediate initiation of CPR with 20% Intralipid bolus (1.5 mL/kg IV over 1 minute) followed by infusion at 0.25 mL/kg/min. This is the only intervention proven to reverse bupivacaine-induced cardiac arrest when standard resuscitation fails. Epinephrine doses should be reduced (≤1 mcg/kg) during lipid infusion. Intralipid is now a mandatory emergency drug in all operating theaters performing regional anesthesia in India, per updated anesthesia protocols.
Why the other options are wrong
B. CPR with dobutamine — Dobutamine is a beta-1 agonist used for inotropic support in cardiogenic shock, but it is ineffective in LAST-induced cardiac arrest. LAST causes direct myocardial toxicity and membrane stabilization that dobutamine cannot overcome. Moreover, catecholamines may worsen arrhythmias in the setting of high local anesthetic levels. This is a trap for students who confuse LAST with septic shock or cardiogenic shock where inotropes are indicated. C. CPR with calcium — Calcium is used in hyperkalemia-induced cardiac arrest (peaked T waves, widened QRS) and calcium channel blocker toxicity, not LAST. While bupivacaine does block calcium channels, giving calcium does not reverse the lipophilic drug's sequestration in myocardial tissue. This option exploits confusion between different causes of drug-induced cardiac arrest and their specific antidotes. D. CPR with sodium bicarbonate — Sodium bicarbonate is indicated for tricyclic antidepressant toxicity (QRS widening, arrhythmias) and severe metabolic acidosis, not LAST. Although LAST may cause acidosis secondarily, bicarbonate does not address the underlying mechanism of bupivacaine-induced myocardial depression. This is a classic NBE trap pairing drug toxicity with a non-specific acid-base intervention.
High-Yield Facts
- LAST (Local Anesthetic Systemic Toxicity) presents as CNS symptoms (restlessness, seizures) followed by cardiovascular collapse (hypotension, bradycardia, asystole) — bupivacaine causes early cardiovascular toxicity.
- 20% Intralipid bolus dose: 1.5 mL/kg IV over 1 minute, then infusion at 0.25 mL/kg/min — this is the ASRA-endorsed protocol now standard in Indian OR protocols.
- Bupivacaine toxicity is refractory to standard ACLS drugs (epinephrine, amiodarone); lipid emulsion is the only proven reversal agent.
- Maximum safe dose of bupivacaine: 2 mg/kg (or 150 mg total) for infiltration; 2.5 mg/kg (or 175 mg) with epinephrine — exceeding this triggers LAST risk.
- Intralipid mechanism: Acts as a lipid sink, sequestering lipophilic bupivacaine away from myocardial and CNS tissue, reducing free drug concentration.
Mnemonics
LAST = Lipid Antidote Saves Toxicity When you see bupivacaine + cardiac arrest → think LAST → reach for Lipid (Intralipid 20%). The lipophilic nature of bupivacaine makes it a lipid-sink drug. ACLS fails in LAST Standard ACLS (epi, amio, calcium) does NOT work in LAST. Only Intralipid reverses the myocardial sequestration. Remember: Lipid toxins need Lipid rescue.
NBE Trap
NBE pairs LAST with standard ACLS drugs (dobutamine, calcium, bicarbonate) to trap students who default to generic cardiac arrest algorithms. The discriminator is recognizing that bupivacaine toxicity is a lipophilic drug overdose requiring lipid sequestration, not catecholamine support or electrolyte correction.
Clinical Pearl
In Indian ORs, LAST is increasingly recognized as a complication of regional anesthesia (spinal, epidural, peripheral nerve blocks). Every anesthesia team must have Intralipid 20% readily available and staff trained in its use — delayed recognition and treatment of LAST can be fatal, but prompt lipid infusion has reversed even asystolic arrests in case reports.
_Reference: Harrison Ch. 381 (Drug Poisoning); ASRA Guidelines on Local Anesthetic Systemic Toxicity (adopted in Indian anesthesia protocols); KD Tripathi Ch. 11 (Local Anesthetics)_